Hi-Clearance Asset Resilience Ratio
Hi-Clearance asset resilience ratio. Hi-Clearance (1788) has an Asset Resilience Ratio of 2.55% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Hi-Clearance (1788) liquidity interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Hi-Clearance (2016–2024)
Asset resilience ratio of Hi-Clearance from 2016 to 2024. This chart shows how Hi-Clearance's Asset Resilience Ratio has changed over time. Read 1788 current and long-term liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Hi-Clearance's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Hi-Clearance assets under control.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$127.12 Million | 2.55% |
| Total Liquid Assets | NT$127.12 Million | 2.55% |
Asset Resilience Insights
- Limited Liquidity: Hi-Clearance maintains only 2.55% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Hi-Clearance Industry Peers by Asset Resilience Ratio
Compare Hi-Clearance's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Applied BioCode
TW:6598 |
Medical Devices | 9.75% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
|
Radiant Innovation
TWO:3373 |
Medical Devices | 0.82% |
|
Impedimed Ltd
AU:IPD |
Medical Devices | 46.15% |
|
Memphasys Ltd
AU:MEM |
Medical Devices | 0.00% |
Hi-Clearance Asset Resilience Ratio by Year (2016–2024)
Hi-Clearance asset resilience ratio by year from 2016 to 2024. The table below shows the annual Asset Resilience Ratio data for Hi-Clearance.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 2.63% | NT$130.66 Million ≈ $4.12 Million |
NT$4.96 Billion ≈ $156.28 Million |
+0.23pp |
| 2023-12-31 | 2.40% | NT$110.86 Million ≈ $3.49 Million |
NT$4.62 Billion ≈ $145.49 Million |
+0.34pp |
| 2022-12-31 | 2.06% | NT$93.01 Million ≈ $2.93 Million |
NT$4.51 Billion ≈ $142.05 Million |
+0.72pp |
| 2021-12-31 | 1.34% | NT$59.55 Million ≈ $1.88 Million |
NT$4.44 Billion ≈ $139.80 Million |
-0.12pp |
| 2020-12-31 | 1.47% | NT$61.65 Million ≈ $1.94 Million |
NT$4.20 Billion ≈ $132.42 Million |
-0.55pp |
| 2019-12-31 | 2.01% | NT$75.07 Million ≈ $2.37 Million |
NT$3.73 Billion ≈ $117.42 Million |
-2.36pp |
| 2018-12-31 | 4.38% | NT$129.95 Million ≈ $4.09 Million |
NT$2.97 Billion ≈ $93.55 Million |
-1.10pp |
| 2017-12-31 | 5.48% | NT$143.14 Million ≈ $4.51 Million |
NT$2.61 Billion ≈ $82.33 Million |
-1.20pp |
| 2016-12-31 | 6.68% | NT$165.10 Million ≈ $5.20 Million |
NT$2.47 Billion ≈ $77.85 Million |
-- |
About Hi-Clearance
Hi-Clearance Inc. supplies medical devices for the renal, cardiac, radiation, dental, oral surgery, and metabolism markets in Taiwan. The company offers dialyzers, dialysis and RO machines, and related consumables and drugs; interventional cardiology and radiology, and vascular surgery devices; dental consumables, implant materials, and equipment; and blood glucose monitors, and related consumabl… Read more